Maharashtra, India

Bramhanand Hanamannavar

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Maharashtra, IN (2022)
  • Mumbai, IN (2022)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Bramhanand Hanamannavar

Introduction

Bramhanand Hanamannavar is an esteemed inventor based in Maharashtra, India, known for his significant contributions to pharmaceutical innovations. With a total of four patents to his name, he has made strides in the development of advanced oral solid dosage forms.

Latest Patents

Among his latest patents, Hanamannavar has developed an "Amorphous Dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide," which features an oral solid dosage form containing a mixture of this compound and a fusible polymeric carrier. This innovative formulation potentially enhances drug delivery mechanisms through amorphous dispersion techniques. Additionally, he has also patented an "Abuse Deterrent Oral Solid Dosage Form," designed to minimize the risks associated with misuse of pharmaceutical products.

Career Highlights

Bramhanand Hanamannavar works at Sun Pharma Advanced Research Company Limited, where he leverages his expertise in pharmaceutical sciences to push the boundaries of drug formulation and delivery. His work reflects a commitment to improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Hanamannavar has collaborated with several talented individuals, including Yashoraj Rupsinh Zala and Nitin Bhalachandra Dharmadhikari. These collaborations have fostered a dynamic environment that promotes the sharing of ideas and expertise, further driving the success of their research initiatives.

Conclusion

Bramhanand Hanamannavar's contributions to the field of pharmaceutical innovations exemplify his passion for enhancing healthcare through technology. With four patents to his name and ongoing work in research, he continues to set benchmarks in the industry, paving the way for future advancements in therapeutic delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…